Table 1A.
Baseline characteristics of participants assigned to the DIAMOND programme (n = 21) or usual care (n = 12). Values are mean (standard deviation) unless stated otherwise
| Intervention (n = 21) | Control (n = 12) | All (n = 33) | |
|---|---|---|---|
| Age, years | 69 (10) | 64 (13) | 67 (11) |
| Gender, femalea | 9 (43) | 9 (75) | 18 (55%) |
| Body mass index, kg/m2 | 34.8 (3.4) | 36.4 (6.3) | 35.4 (4.7) |
| Weight, kg | 103.0 (16.7) | 97.6 (13.2) | 101.0 (15.6) |
| Height, m | 1.7 (0.1) | 1.6 (0.1) | 1.7 (0.1) |
| HbA1c, mmol/mol | 63.2 (14.8) | 57.1 (8.3) | 61.0 (13) |
| Systolic blood pressure, mmHg | 144 (20) | 132 (14) | 140 (19) |
| Diastolic blood pressure, mmHg | 84 (10) | 78 (7) | 82 (9) |
| Duration of diabetes, years | 9.0 (5.2) | 9.5 (7.9) | 9.2 (6.1) |
| HbA1c above target at baseline (HbA1c >53 mmol/mol) † | 14 (67) | 8 (67) | 22 (67) |
| Ethnic group a | |||
| White | 21 (100) | 10 (83) | 31 (94) |
| Black or Asian | 0 (0) | 0 (0) | 0 (0) |
| Mixed or other | 0 (0) | 2 (17) | 2 (6) |
| Education a | |||
| No formal qualifications | 8 (38) | 4 (33) | 12 (36) |
| Secondary education | 9 (43) | 3 (25) | 12 (36) |
| Higher education | 4 (19) | 5 (42) | 9 (27) |
| Relevant medications | |||
| Number of diabetes medications | 1.4 (0.9) | 1.1 (0.9) | 1.3 (0.9) |
| Number of antihypertensive medications | 1.4 (1.5) | 1.4 (1.1) | 1.4 (1.3) |
a
number of participants (%).